Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 10/20 | 0.43 |
| ▸ | NPY1R | P25929 | 5/20 | 0.42 |
| ▸ | NPY2R | P49146 | 5/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.42 |
| ▸ | CCKBR | P32239 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22117577 | 1.00 | CTSS (0.52) | CTSSNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22117579 | 0.94 | CTSS (0.58) | CTSSCCKBR | |
| SCHEMBL22117578 | 0.94 | CTSS (0.58) | CTSSCCKBR | |
| SCHEMBL22117409 | 0.94 | REN (0.48) | CTSSNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22117410 | 0.94 | REN (0.48) | CTSSNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28652461 | 0.90 | CTSS (0.48) | CTSSNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28652457 | 0.90 | CTSS (0.48) | CTSSNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31679016 | 0.87 | KLK7 (0.50) | CTSSNPY4RCCKBR | |
| SCHEMBL31679022 | 0.86 | CTSL (0.51) | NPY4RNPY1RNPY2RNPY5RCCKBR | |
| SCHEMBL22117422 | 0.86 | REN (0.54) | CTSSNPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898652-A1 | MITOCHONDRIA-TARGETING PEPTIDES | Stealth Biotherapeutics Corp (MC) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020131282-A1 | MITOCHONDRIA-TARGETING PEPTIDES | STEALTH BIOTHERAPEUTICS CORP. (MC) | 2020-06-25 | — | — | WO | disclosed |